Growing community of inventors

Nakago, Japan

Hongbo Qin

Average Co-Inventor Count = 8.00

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 0

Hongbo QinMuneto Mogi (3 patents)Hongbo QinToshio Kawanami (3 patents)Hongbo QinYuki Iwaki (3 patents)Hongbo QinHidetomo Imase (3 patents)Hongbo QinKayo Yasoshima (3 patents)Hongbo QinKen Yamada (3 patents)Hongbo QinIchiro Umemura (3 patents)Hongbo QinOsamu Ohmori (8 patents)Hongbo QinTakahiro Miyake (7 patents)Hongbo QinMuneto Mogi (0 patent)Hongbo QinHidetomo Imase (0 patent)Hongbo QinToshio Kawanami (0 patent)Hongbo QinKayo Yasoshima (0 patent)Hongbo QinKen Yamada (0 patent)Hongbo QinYuki Iwaki (0 patent)Hongbo QinHongbo Qin (3 patents)Muneto MogiMuneto Mogi (32 patents)Toshio KawanamiToshio Kawanami (19 patents)Yuki IwakiYuki Iwaki (17 patents)Hidetomo ImaseHidetomo Imase (15 patents)Kayo YasoshimaKayo Yasoshima (14 patents)Ken YamadaKen Yamada (13 patents)Ichiro UmemuraIchiro Umemura (13 patents)Osamu OhmoriOsamu Ohmori (8 patents)Takahiro MiyakeTakahiro Miyake (7 patents)Muneto MogiMuneto Mogi (0 patent)Hidetomo ImaseHidetomo Imase (0 patent)Toshio KawanamiToshio Kawanami (0 patent)Kayo YasoshimaKayo Yasoshima (0 patent)Ken YamadaKen Yamada (0 patent)Yuki IwakiYuki Iwaki (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (3 from 3,923 patents)


3 patents:

1. 8440682 - 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors

2. 8420641 - Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives

3. 8193349 - 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/7/2026
Loading…